Indo-Bangla Pharmaceuticals (DHA:IBP) Total Operating Expense: BDT0.00 Mil (TTM As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT17.90
View Full Analysis

What is Indo-Bangla Pharmaceuticals Total Operating Expense?

Indo-Bangla Pharmaceuticals DHA:IBP +1.70% 32 Total Operating Expense is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's Total Operating Expense for the six months ended in . 20 was BDT0.00 Mil. Indo-Bangla Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Total Operating Expense Related Terms

Indo-Bangla Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Total Operating Expense Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Total Operating Expense

Indo-Bangla Pharmaceuticals Semi-Annual Data
Total Operating Expense
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of BDT0.00 Mil mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Total Operating Expense of BDT0.00 Mil as of . 20. Total operating expense is the primary recurring expense associated with central operations. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Total Operating Expense too high?
Indo-Bangla Pharmaceuticals' current Total Operating Expense is BDT0.00 Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Total Operating Expense compare to ?
Indo-Bangla Pharmaceuticals' Total Operating Expense of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Total Operating Expense is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Total Operating Expense of BDT0.00 Mil. The current Total Operating Expense is BDT0.00 Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Total Operating Expense is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT17.90
Price